1. Home
  2.  » 
  3. Our Locations
  4.  » 
  5. North America
  6.  » St. Petersburg, USA


St. Petersburg is our primary softgel development and manufacturing facility in North America with capacity of 18 billion capsules per year. The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candicates. Non-gelatin based OptiShell® and Vegicaps® capsules expand the range of molecules into softgel, ideal for challenging fill formulation. Within the Catalent network, we offer a broad range of integrated formulation and analytical services to solve your most difficult development and manufacturing challenges.

Size: 453,000 ft2


2725 Scherer Drive North,
St. Petersburg, FL 33716


+1 727 803 2100

Title Address Description
St. Petersburg, FL Location
2725 Scherer Dr, St. Petersburg, FL 33716, USA


  • EMA/MHRA Approved
  • FDA Approved
  • PMDA
  • CFDA (China)
  • MOH (Saudi Arabia, Turkey)
  • MFDS


Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume, or contact us at careers@catalent.com.